A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

August 17, 2017

Primary Completion Date

December 18, 2018

Study Completion Date

December 18, 2018

Conditions
Colitis, Ulcerative
Trial Locations (15)

2447

Kyung Hee University Hospital, Seoul

3080

Seoul National University Hospital, Seoul

3181

Kangbuk Samsung Hospital, Seoul

3722

Severance Hospital, Yonsei University Health System, Seoul

5505

Asan Medical Center, Seoul

6273

Gangnam Severance Hospital, Yonsei University Health System, Seoul

6351

Samsung Medical Center, Seoul

13620

Seoul National University Bundang Hospital, Seongnam-si

16247

The Catholic University of Korea, St. Vincent's Hospital, Suwon

31116

Dankook University Hospital, Cheonan-si

34943

The Catholic University of Korea, Daejeon St. Mary's Hospital, Daejeon

41944

Kyungpook National University Hospital, Daegu

42415

Youngnam University Hospital, Daegu

42644

Goo Hospital, Daegu

48108

Inje University Haeundae Paik Hospita, Busan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY